Human Papillomavirus Infection and the Multistage Carcinogenesis of Cervical Cancer
- 1 April 2013
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 22 (4), 553-560
- https://doi.org/10.1158/1055-9965.epi-12-1406
Abstract
This short review outlines our understanding of cervical cancer precursors, concentrating on the central etiologic role of persistent human papillomavirus infection. The stages of cervical carcinogenesis are better understood than for most other major cancers, providing a successful cancer etiology and prevention model. Cancer Epidemiol Biomarkers Prev; 22(4); 553–60. ©2013 AACR.Keywords
This publication has 51 references indexed in Scilit:
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical CancerVaccine, 2012
- A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancerProceedings of the National Academy of Sciences of the United States of America, 2012
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practiceThe Lancet Oncology, 2011
- Switch from cytology‐based to human papillomavirus test‐based cervical screening: Implications for colposcopyInternational Journal of Cancer, 2011
- Estrogen and ERα: Culprits in cervical cancer?Trends in Endocrinology & Metabolism, 2010
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenThe Lancet, 2009
- Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinantsInternational Journal of Cancer, 2009
- A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural ChinaThe Lancet Oncology, 2008
- The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical PracticeJNCI Journal of the National Cancer Institute, 2005
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002